134 related articles for article (PubMed ID: 1728304)
1. Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas.
van Endert PM; Heilig B; Hämmerling GJ; Moldenhauer G
Blood; 1992 Jan; 79(1):129-37. PubMed ID: 1728304
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional changes of tumour cells from patients treated with monoclonal anti-idiotypic antibodies.
Allebes WA; Knops R; Bontrop RE; Otting N; Raemakers J; Haanen C; Capel PJ
Scand J Immunol; 1990 Nov; 32(5):441-9. PubMed ID: 2270431
[TBL] [Abstract][Full Text] [Related]
3. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
Racila E; Scheuermann RH; Picker LJ; Yefenof E; Tucker T; Chang W; Marches R; Street NE; Vitetta ES; Uhr JW
J Exp Med; 1995 Apr; 181(4):1539-50. PubMed ID: 7535341
[TBL] [Abstract][Full Text] [Related]
4. Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma.
Chatterjee M; Barcos M; Han T; Liu XL; Bernstein Z; Foon KA
Blood; 1990 Nov; 76(9):1825-9. PubMed ID: 2224130
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes.
Wrightham M; Tutt AL; Glennie MJ; Hamblin TJ; Stevenson GT; Stevenson FK
Blood; 1987 Mar; 69(3):919-23. PubMed ID: 2434161
[TBL] [Abstract][Full Text] [Related]
6. Idiotypic determinants on monoclonal autoantibodies to the Thy-1 antigen.
Rabinowitz R; Thomas DB; Hadar R; Schlesinger M
Immunology; 1988 Jan; 63(1):9-15. PubMed ID: 2448234
[TBL] [Abstract][Full Text] [Related]
7. Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome).
Bertoli LF; Kubagawa H; Borzillo GV; Mayumi M; Prchal JT; Kearney JF; Durant JR; Cooper MD
Blood; 1987 Jul; 70(1):45-50. PubMed ID: 3297206
[TBL] [Abstract][Full Text] [Related]
8. Requirements for induction of activation and proliferation of human B cells analysed with anti-idiotype monoclonal antibodies.
de Rie MA; van Lier RA; Imholz MJ; Schumacher TN; van Schijndel GM; Miedema F
Scand J Immunol; 1989 Aug; 30(2):249-57. PubMed ID: 2474851
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
10. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
Haimovich J; Kukulansky T; Weissman B; Hollander N
Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
[TBL] [Abstract][Full Text] [Related]
11. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
Mongini PK; Blessinger C; Posnett DN; Rudich SM
J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory and stimulatory signaling via immunoglobulin receptors: dichotomous responses elicited in clonal B cell populations.
Van Endert PM; Moldenhauer G
Eur J Immunol; 1992 May; 22(5):1229-35. PubMed ID: 1577065
[TBL] [Abstract][Full Text] [Related]
13. Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells.
Cairns E; Massicotte H; Bell DA
J Clin Invest; 1989 Mar; 83(3):1002-9. PubMed ID: 2493481
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin receptor signaling depends on the carboxyl terminus but not the heavy-chain class.
Webb CF; Nakai C; Tucker PW
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1977-81. PubMed ID: 2494658
[TBL] [Abstract][Full Text] [Related]
15. Production of mouse monoclonal antibodies for the analysis of idiotypes in serum of patients with chronic lymphatic leukaemia.
de Rie MA; van Heemstra DJ; Huijgens PC; Zeijlemaker WP; Out TA; Melief CJ; von dem Borne AE
Br J Haematol; 1988 Jan; 68(1):11-6. PubMed ID: 3257881
[TBL] [Abstract][Full Text] [Related]
16. In vivo study of mIgM and mIgD cross-linking on murine B cells.
Denis O; Macedo-Soares F; Latinne D; Nisol F; Bazin H
Scand J Immunol; 1994 Jun; 39(6):625-32. PubMed ID: 8009179
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies.
White CA; Halpern SE; Parker BA; Miller RA; Hupf HB; Shawler DL; Collins HA; Royston I
Blood; 1996 May; 87(9):3640-9. PubMed ID: 8611688
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphatidylinositol 3-kinase in anti-IgM- and anti-IgD-induced apoptosis in B cell lymphomas.
Carey GB; Scott DW
J Immunol; 2001 Feb; 166(3):1618-26. PubMed ID: 11160203
[TBL] [Abstract][Full Text] [Related]
19. Crossreacting human lymphoma idiotypes.
Rudders RA; Levin A; Jespersen D; Zacks J; Delellis R; Ranger A; Krontiris T
Blood; 1992 Aug; 80(4):1039-44. PubMed ID: 1379849
[TBL] [Abstract][Full Text] [Related]
20. The development of non-responsiveness to immunotherapy with monoclonal anti-idiotypic antibodies in a patient with B-CLL.
Allebes WA; Preijers FW; Haanen C; Capel PJ
Br J Haematol; 1988 Nov; 70(3):295-300. PubMed ID: 3207626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
